Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.
about
The place of immunotherapy in the management of HCV-induced vasculitis: an updateCost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in IrelandBiologic treatment in Sjögren's syndrome.Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide.
P2860
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.
@ast
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.
@en
type
label
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.
@ast
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.
@en
prefLabel
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.
@ast
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.
@en
P2093
P2860
P1433
P1476
Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey.
@en
P2093
Charléric Bornet
Gilles Kaplanski
Jean-Marc Durand
Jean-Robert Harlé
Laurent Chiche
Nicolas Schleinitz
Raphaelle Fanciullino
Rodolphe Jean
Souleymane Brah
P2860
P304
P356
10.1007/S00277-011-1283-3
P577
2011-06-28T00:00:00Z